Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Targeted Genetics receives patent protection for tgDCC-E1A

Aug. 26, 1997

Microtubule inhibitor with low toxicity and unique profile of CaM activity

Aug. 25, 1997

Apoptosis modulators reported in patent literature

Aug. 22, 1997

Telomerase-inhibitory oligonucleotides for treating cancer

Aug. 22, 1997

Laserscope receives approvable letter from FDA

Aug. 21, 1997

New antitumor agents discovered at Sagami

Aug. 21, 1997

NIH announces discovery of new breast cancer gene

Aug. 20, 1997

Pfizer enters phase I trials with CP-358774

Aug. 20, 1997

Endorex licenses anticancer drug perillyl alcohol

Aug. 20, 1997

Bristol-Myers Squibb describes new taxanes

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...